Moderna
MRNA
#1187
Rank
NZ$27.10 B
Marketcap
$70.43
Share price
7.48%
Change (1 day)
-45.75%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$0.14 B3.95%
2023NZ$0.13 B-50.15%
2022NZ$0.27 B-85.7%
2021NZ$1.90 B158.2%
2020NZ$0.73 B369.18%
2019NZ$0.15 B1011.49%
2018NZ$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$0.86 MNZ$6.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.45 MNZ$88.44 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.09 MNZ$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.34 MNZ$44.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.57 MNZ$74.81 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$0.64 MNZ$10.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$70.18 MNZ$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA